Harry A Albrecht

Title: The Innovations of Harry A. Albrecht

Introduction

Harry A. Albrecht is a notable inventor based in Towaco, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial compounds. With a total of 7 patents to his name, Albrecht's work has had a considerable impact on antimicrobial therapies.

Latest Patents

Albrecht's latest patents focus on antibacterial cephalosporin compounds. These compounds exhibit broad antimicrobial activity and are characterized by specific chemical formulas. The first patent presents antibacterial cephalosporins with a formula where R can be hydrogen or a carboxylic acid-protecting group. The piperazinyl or pyrrolidinyl groups in the compounds may be substituted with lower alkyl groups, while Q represents a substituted quinolinyl or naphthyridinyl group. The second patent also details similar antibacterial cephalosporins and their intermediates, emphasizing the importance of these compounds in pharmaceutical applications.

Career Highlights

Harry A. Albrecht has had a distinguished career, working at Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His innovative work has contributed to advancements in antibiotic treatments, showcasing his expertise in medicinal chemistry.

Collaborations

Throughout his career, Albrecht has collaborated with notable colleagues, including Dennis D. Keith and Frederick M. Konzelmann. These partnerships have fostered a collaborative environment that has led to significant advancements in their field.

Conclusion

Harry A. Albrecht's contributions to the field of antibacterial compounds highlight his role as a key innovator in pharmaceuticals. His patents and collaborations reflect a commitment to advancing medical science and improving health outcomes.